Bausch & Lomb BLCO
NYSE BLCO
$17.09 +0.14 (+0.83%)
At close: Oct 2, 2026 · 4:00 PM EDT

Bausch & Lomb (BLCO) Gains from Sales and Divestitures (2024 - 2026)

Updated

Bausch & Lomb (BLCO) recorded Gains from Sales and Divestitures of $3 million in Q1 2026.

Analysis

Bausch & Lomb (BLCO) Gains from Sales and Divestitures (2024 - 2026) Analysis & Trends

For FY2025, Bausch & Lomb reported Gains from Sales and Divestitures of $6 million, up 20.0% from FY2024.

  • Across earlier years, Gains from Sales and Divestitures came in at $5 million in FY2024.
  • The Q1 2026 figure is the lowest quarterly Gains from Sales and Divestitures since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Bausch & Lomb 6.10 Bn 4.84 Bn 867.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.00 Mn
Sep 30, 2025 6.00 Mn
Jun 30, 2024 1.00 Mn
Mar 31, 2024 4.00 Mn
API Access

Bausch & Lomb Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=BLCO&period=max&api_key=YOUR_API_KEY